Decreased apoptosome activity with neuronal differentiation sets the threshold for strict IAP regulation of apoptosis by Wright, Kevin M. et al.
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
I
O
L
O
G
Y
 
©
 
 The Rockefeller University Press $8.00
The Journal of Cell Biology, Vol. 167, No. 2, October 25, 2004 303–313
http://www.jcb.org/cgi/doi/10.1083/jcb.200406073
 
JCB: ARTICLE
 
JCB 303
 
Decreased apoptosome activity with neuronal 
differentiation sets the threshold for strict IAP 
regulation of apoptosis
 
Kevin M. Wright,
 
1
 
 Michael W. Linhoff,
 
2
 
 Patrick Ryan Potts,
 
2
 
 and Mohanish Deshmukh
 
2
 
1
 
Curriculum in Neurobiology and 
 
2
 
Neuroscience Center and the Department of Cell and Developmental Biology, University of North Carolina, Chapel Hill, NC 27599
 
espite the potential of the inhibitor of apoptosis
proteins (IAPs) to block cytochrome 
 
c
 
–dependent
caspase activation, the critical function of IAPs in
regulating mammalian apoptosis remains unclear. We re-
port that the ability of endogenous IAPs to effectively reg-
ulate caspase activation depends on the differentiation
state of the cell. Despite being expressed at equivalent
levels, endogenous IAPs afforded no protection against
cytochrome 
 
c
 
–induced apoptosis in naïve pheochromocy-
toma (PC12) cells, but were remarkably effective in doing
D
 
so in neuronally differentiated cells. Neuronal differentia-
tion was also accompanied with a marked reduction in
Apaf-1, resulting in a signiﬁcant decrease in apoptosome
activity. Importantly, this decrease in Apaf-1 protein was
directly linked to the increased ability of IAPs to strin-
gently regulate apoptosis in neuronally differentiated
PC12 and primary cells. These data illustrate speciﬁcally
how the apoptotic pathway acquires increased regulation
with cellular differentiation, and are the ﬁrst to show that
IAP function and apoptosome activity are coupled in cells.
 
Introduction
 
Activation of the caspase proteases is a crucial event at which cells
become committed to die by apoptosis (Denault and Salvesen,
2002). In most mammalian cells, caspases become activated when
apoptotic signaling pathways converge at the mitochondria to trig-
ger the release of cytochrome 
 
c
 
. Cytochrome 
 
c
 
, Apaf-1, and pro-
caspase-9 oligomerize to form the apoptosome complex, resulting
in the activation of caspase-9. This results in the activation of cas-
pase-3, inducing rapid apoptosis and cell death (Wang, 2001).
The inhibitor of apoptosis proteins (IAPs) are a family of
proteins that can block apoptosis by directly binding to activated
caspases (Deveraux and Reed, 1999). Mammalian IAPs include
NAIP, cIAP-1, cIAP-2, and XIAP, and are characterized by the
presence of 1–3 baculovirus IAP repeat domains (Salvesen and
Duckett, 2002). Addition of purified IAPs to cell extracts blocks
cytochrome 
 
c
 
–mediated caspase activation (Deveraux and Reed,
1999). Likewise, overexpression of IAPs inhibits apoptosis after
the point of cytochrome 
 
c
 
 release in cells (Duckett et al., 1998;
Ekert et al., 2001). IAPs themselves can be inhibited by proteins
such as Smac/Diablo and HTRA2/Omi, which translocate from
the mitochondria to the cytosol after apoptotic stimuli (Du et al.,
2000; Verhagen et al., 2000; Suzuki et al., 2001; Shi, 2002).
Despite their identification and widespread expression,
however, the critical function of endogenous IAPs and their
inhibitors in regulating apoptosis in mammalian cells remains
unclear. Mice carrying deletions in either XIAP or Smac
genes exhibit no gross morphological defects (Harlin et al.,
2001; Okada et al., 2002). Importantly, in many mitotic cells,
such as HeLa cells, HEK 293 cells, and fibroblasts, the en-
dogenously expressed IAPs appear incapable of regulating
apoptosis postcytochrome 
 
c
 
, as cytosolic cytochrome 
 
c
 
 alone
is sufficient to activate caspases and induce apoptosis. In
these cells, addition of cytochrome 
 
c
 
 to cytosolic lysates trig-
gers robust caspase activation in vitro (Liu et al., 1996; Kluck
et al., 1997; Hu et al., 1999), and microinjection of cyto-
chrome 
 
c
 
 is sufficient to induce rapid cell death in intact cells
(Li et al., 1997; Brustugun et al., 1998; Juin et al., 1999;
Chang et al., 2000).
In contrast, endogenous IAPs are highly effective in regu-
lating caspase activation in postmitotic sympathetic neurons
(postnatal day 5 [P5]), as these neurons are remarkably resis-
tant to cytochrome 
 
c
 
 and undergo apoptosis only when IAP in-
hibition is relieved (Deshmukh and Johnson, 1998; Neame et
al., 1998; Deshmukh et al., 2002). Recently, XIAP was identi-
fied as the critical IAP regulating caspase activation in sympa-
thetic neurons. Although cytosolic cytochrome 
 
c
 
 is unable to
induce apoptosis in wild-type neurons, it does so rapidly in
XIAP-deficient neurons (Potts et al., 2003).
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The observation that apoptosis is strictly controlled by
endogenous IAPs in sympathetic neurons, but not in many mi-
totic nonneuronal cells, is consistent with the general notion
that apoptosis may be under tighter regulation in postmitotic
cells such as neurons because these cells do not divide and need
to last for the life of the organism. However, this raises two
questions. First, is the stringent postcytochrome 
 
c
 
 regulation of
apoptosis by IAPs a fundamental mechanism that becomes en-
gaged when cells undergo neuronal differentiation? Second,
how is it that the endogenous levels of IAPs are ineffective in
regulating apoptosis in many mitotic cells, but become very ef-
fective in neurons despite similar levels of expression? Here,
we examined these questions in the model of differentiating rat
pheochromocytoma (PC12) cells (Greene and Tischler, 1976;
Greene, 1978), as well as in primary fibroblasts and neurons.
 
Results
 
Cytochrome 
 
c
 
 is sufficient to activate 
caspases and induce apoptosis in naïve 
but not in neuronally differentiated 
PC12 cells
 
PC12 cells can exist either as mitotic naïve cells, or can be dif-
ferentiated with NGF treatment into postmitotic, neuronal-like
cells (Greene and Tischler, 1976; Greene, 1978). Both naïve
and neuronally differentiated PC12 cells undergo a Bcl-2 in-
hibitable, caspase-dependent apoptosis in response to a variety
of apoptotic stimuli (Mesner et al., 1992; Batistatou et al.,
1993; Pittman et al., 1993; Mills et al., 1995; Troy et al., 1996).
To determine whether cellular differentiation of mitotic cells
into postmitotic neurons induces a change in the postcyto-
chrome 
 
c
 
 regulation of apoptosis, we examined whether cyto-
solic cytochrome 
 
c
 
 was sufficient to induce apoptosis in naïve
or neuronally differentiated PC12 cells. Naïve PC12 cells were
differentiated with NGF for 12 d, during which the cells be-
come postmitotic and extend neurites (Fig. 1 A) (Greene and
Tischler, 1976; Pittman et al., 1993).
Cytosolic microinjection of cytochrome 
 
c
 
 induced exten-
sive cell death within 30 min in naïve cells. In contrast, upon
neuronal differentiation, these cells became remarkably resis-
tant, with 90% of cells viable 30 min after microinjection of cy-
tochrome 
 
c
 
 (Fig. 1, A and B). Even 3 h after the injections,
 
 
 
60% of neuronally differentiated cells remained alive (Fig. 1
B), with viability slowly decreasing at later (12–24 h) time
points (unpublished data). This resistance to cytochrome 
 
c
 
 was
acquired gradually, with 50% of maximum resistance seen only
after 8 d of differentiation with NGF (Fig. S1, A and B, available
at http://www.jcb.org/cgi/content/full/jcb.200406073/DC1).
We examined whether the differential ability of cyto-
chrome 
 
c
 
 to induce apoptosis in naïve and neuronally differen-
Figure 1. Addition of exogenous cytochrome c induces caspase activation and apoptosis in naïve but not neuronally differentiated PC12 cells. (A) Naïve
and neuronally differentiated PC12 cells were injected with 10–15 mg/ml cytochrome c or rhodamine dextran alone. Injected cells (arrows) were identi-
fied by the presence of rhodamine dextran coinjected with the cytochrome c. (B) Viability of naïve and neuronally differentiated cells at multiple times after
the injections. Data shown are mean   SEM of three independent experiments. (C) Cytosolic lysates from naïve and neuronally differentiated PC12 cells
were assessed for caspase activation after the addition of 10  M cytochrome c by measuring cleavage of the fluorogenic caspase substrate DEVD-afc. 10
 M yeast cytochrome c or 7 U granzyme B was added to lysates as a negative or positive control, respectively, for caspase activation. (D) Western anal-
ysis showing the status of caspase-9 (top) and caspase-3 (bottom) cleavage in cytosolic lysates from naïve and neuronally differentiated cells treated as de-
scribed in C. Data shown are representative of at least three independent experiments. 
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tiated PC12 cells was also seen in cell-free extracts. Although
addition of cytochrome 
 
c
 
 was sufficient to induce robust cas-
pase activation in cytosolic lysates of naïve cells, no significant
caspase activation was detected in cytosolic lysates of neu-
ronally differentiated cells (Fig. 1 C). Control yeast cyto-
chrome 
 
c
 
 protein, which is unable to bind Apaf-1 (Ellerby et
al., 1997; Kluck et al., 2000), did not activate caspases in either
naïve or neuronally differentiated cells. We examined whether
the resistance to cytochrome 
 
c
 
 in neuronally differentiated cells
was because of a deficit in procaspase-3. Levels of procaspase-3
were in fact found to be slightly higher in neuronally differ-
entiated cells compared with naïve cells (Fig. S2 A, available at
http://www.jcb.org/cgi/content/full/jcb.200406073/DC1) (Rong
et al., 1999). Importantly, addition of granzyme B, which can
directly activate caspase-3 (Trapani and Sutton, 2003), induced
robust caspase activation in lysate from both naïve and neu-
ronally differentiated PC12 cells (Fig. 1 C). Thus, the inability
of cytochrome 
 
c
 
 to activate caspases in neuronally differentiated
cells was not because of a defect in caspase-3.
Apoptosome-mediated cleavage of caspase-9 generates a
35-kD and a 12-kD fragment (Liu et al., 1996; Cain et al.,
2002). Activated caspase-9 then cleaves and activates caspase-3,
which can also feedback on unprocessed procaspase-9 to
cleave it into a 37-kD and a 10-kD fragment (Srinivasula et al.,
1998; Zou et al., 2003). In naïve cell lysates, the addition of bo-
vine cytochrome 
 
c
 
, but not yeast cytochrome 
 
c
 
, induced signif-
icant processing of caspase-9 and caspase-3 (Fig. 1 D). In con-
trast, in neuronally differentiated PC12 cell lysates, consistent
with the inability of cytochrome 
 
c
 
 to induce apoptosis, no sig-
nificant processing of caspase-9 or caspase-3 was detected. Ad-
dition of granzyme B induced robust and equivalent processing
of caspase-9 and caspase-3 in both naïve and neuronally differ-
entiated PC12 cells (Fig. 1 D). Together, these results show
that although cytosolic cytochrome 
 
c
 
 was sufficient to activate
caspases and induce death in naïve cells, upon postmitotic dif-
ferentiation these cells became markedly resistant as shown in
both intact cells and in cell-free extracts.
 
Resistance to cytochrome 
 
c
 
–induced 
apoptosis in neuronally differentiated 
cells is mediated by endogenous IAPs
 
In primary sympathetic neurons, the resistance to cytochrome
 
c
 
–induced apoptosis is mediated by endogenous IAPs (Desh-
mukh et al., 2002; Potts et al., 2003). To determine whether a
similar IAP-mediated regulation was promoting resistance to
cytochrome 
 
c
 
 in neuronally differentiated PC12 cells, we ex-
amined whether addition of Smac, an IAP inhibitor, could
relieve the inhibition and permit cytochrome 
 
c
 
 to activate
caspases in these cells. Addition of wild-type mature Smac
(AVPI-Smac) and cytochrome 
 
c
 
 together resulted in increased
caspase activation in cytosolic extracts from neuronally differ-
entiated cells that are otherwise resistant to addition of cyto-
chrome 
 
c
 
 or AVPI-Smac alone (Fig. 2 A; unpublished data).
The concentration of Smac used in these experiments was max-
imal, as a 10-fold increase in Smac did not result in any further
increase in caspase activation in cell extracts. Importantly, un-
like wild-type AVPI-Smac, mutant MVPI-Smac, which is un-
able to bind to IAPs and inhibit their function (Chai et al.,
2000), did not enhance cytochrome 
 
c
 
–mediated caspase activa-
tion in these cell extracts (Fig. 2 A).
We also examined whether excess Smac could allow cyto-
chrome 
 
c
 
 to induce death in intact neuronally differentiated cells.
Coinjection of cytochrome 
 
c
 
 with wild-type AVPI-Smac induced
significantly greater death in neuronally differentiated cells than
seen with injection of cytochrome 
 
c
 
 alone or mutant MVPI-Smac
and cytochrome 
 
c
 
 together (Fig. 2 B). These results show that en-
Figure 2. Exogenous addition of Smac that
can relieve IAP inhibition permits cytochrome c
to activate caspases and induce death in neu-
ronally differentiated PC12 cells. Neuronally
differentiated (A and B) or naïve (C and D)
PC12 cells were treated with either cyto-
chrome c alone, cytochrome c and wild-type
AVPI-Smac, or cytochrome c and mutant MVPI-
Smac. These proteins were either added to
cytosolic lysates prepared from naïve or neu-
ronally differentiated cells (Cyt c, 10  M;
Smac, 1  M) and assessed for their ability to
activate caspases by the DEVD-afc cleavage
assay (A and C) or injected into intact naïve
or neuronally differentiated cells (Cyt c, 10
mg/ml; Smac, 1 mg/ml) and assessed for
their ability to induce cell death (B and D).
Data shown are mean   SEM (B and D) or
representative (A and C) of at least three inde-
pendent experiments. 
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dogenous IAPs effectively inhibited cytochrome 
 
c
 
–mediated cas-
pase activation and death in neuronally differentiated cells. In
contrast, endogenous IAPs did not appear to regulate apoptosis
in the naïve, undifferentiated cells. Not only was cytochrome 
 
c
 
alone sufficient to induce rapid cell death in naïve cells, but in-
hibiting IAPs with addition of Smac did not enhance the rate of
caspase activation or cell death in these cells (Fig. 2, C and D).
 
Apoptosome becomes highly inefficient in 
neuronally differentiated cells
 
The selective ability of endogenous IAPs to block caspase acti-
vation in neuronally differentiated but not naïve cells was not
due to elevated expression of IAPs in the neuronally differenti-
ated cells. Naïve and neuronally differentiated PC12 cells
expressed similar levels of multiple IAPs, including XIAP,
cIAP-1, cIAP-2, and NAIP (Fig. 3, A and B).
Because inhibition of IAPs with Smac permitted cyto-
chrome 
 
c
 
 to activate caspases in neuronally differentiated cells
(Fig. 2), we examined the processing of caspases when Smac
was added to the naïve and neuronally differentiated extracts.
Cytochrome 
 
c
 
–mediated activation of the apoptosome was very
efficient in naïve cell extracts as the apoptosome-processed,
p35-kD form of processed caspase-9 predominated over the
caspase-3 feedback-cleaved, p37-kD form of caspase-9 (Fig. 3
C). Because cleavage of caspase-9 may not necessarily corre-
late with caspase-9 activity (Stennicke et al., 1999; Srinivasula
et al., 2001), we also examined the processing of caspase-3 as
an indicator of caspase-9 activity. Cytochrome 
 
c
 
 induced robust
processing of caspase-3 in naïve cells, and relieving IAPs with
Smac did not enhance this processing (Fig. 3 C).
In contrast, the apoptosome appeared highly inefficient in
neuronally differentiated cells as very little caspase-9 processing,
neither apoptosome mediated nor feedback cleaved by caspase-3,
was detected when cytochrome 
 
c
 
 was added to these extracts
(Fig. 3 C). Relieving IAP inhibition with wild-type AVPI-Smac
in neuronally differentiated extracts permitted cytochrome 
 
c
 
 to
activate a limited amount of caspase-3, as some caspase-3 feed-
back-cleaved form of caspase-9 (p37) was detected under these
conditions (Fig. 3 C). Importantly however, the apoptosome re-
mained highly inefficient even under these conditions, as no sig-
nificant increase in the apoptosome-mediated processing of cas-
pase-9 (p35) was observed even when Smac was added to
neuronally differentiated extracts. Furthermore, the amount of
processed caspase-3 that was observed in neuronally differenti-
ated cells with Smac addition, although adequate to induce cell
death, was significantly lower than seen in naïve cells (Fig. 3 C).
Thus, although Smac addition resulted in an increase in caspase-3
activation sufficient for cell death in neuronally differentiated
cells, a marked decrease in the efficiency of apoptosome activity
occurred when naïve cells became neuronally differentiated.
 
Efficiency of apoptosome sets the 
threshold for IAPs to inhibit apoptosis in 
cells
 
If the differential ability of endogenous IAPs to regulate cyto-
chrome 
 
c
 
–mediated caspase activation in naïve and neuronally
Figure 3.  Naïve and neuronally differentiated cells ex-
press similar levels of IAPs. (A) Protein levels of XIAP,
cIAP-1, cIAP-2, NAIP, and lactate dehydrogenase (LDH)
were examined in naïve and neuronally differentiated
PC12 cells (equal total protein loaded) by Western analy-
sis. (B) Quantitation of protein levels from three indepen-
dent experiments are shown as mean    SEM. (C)
Marked reduction in apoptosome activity with neuronal
differentiation. Cytosolic lysates from naïve and neu-
ronally differentiated cells were treated with either bovine
cytochrome c alone (10  M), yeast cytochrome c as a
control (10  M), or bovine cytochrome c with 1  M of
either wild-type AVPI-Smac or mutant MVPI-Smac. Cleav-
age of caspase-9 and caspase-3 in these treated extracts
was examined by Western analysis. 
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differentiated cells is linked to the differential efficiencies of
the apoptosome in these two cell types, two simple predictions
result from this model. First, reducing the efficiency of the apop-
tosome in naïve cells should allow endogenous IAPs to now
tightly regulate cytochrome 
 
c
 
–mediated caspase activation.
Second, increasing the efficiency of the apoptosome in neu-
ronally differentiated cells should eliminate the stringent IAP-
mediated regulation of caspase activation seen normally in
these cells.
To reduce apoptosome function in naïve cells, we
simply decreased the amount of exogenous cytochrome 
 
c
 
,
thereby limiting the amount of apoptosome formation that
could occur in these cells. Serial dilutions of cytochrome 
 
c
 
were added to cytosolic lysate from naïve PC12 cells, causing
a dose-dependent decrease in caspase activation (Fig. 4 A).
To determine whether the reduced caspase activation was be-
cause of an increased ability of endogenous IAPs to inhibit
caspase activation in these cells, we examined whether reliev-
ing IAP inhibition with Smac addition enhanced caspase acti-
vation seen with suboptimum cytochrome 
 
c
 
. Indeed, addition
of wild-type AVPI-Smac to lysates with suboptimum cyto-
chrome 
 
c
 
 (100 nM) effectively increased the amount of cas-
pase activation as compared with lysates with suboptimum
cytochrome 
 
c
 
 alone (Fig. 4 B).
Additionally, serial dilutions of cytochrome 
 
c
 
 were in-
jected into intact naïve cells to identify a concentration of cyto-
chrome 
 
c
 
 that was ineffective in inducing cell death (Fig. 4 C).
At the suboptimal dose of 100 
 
 
 
g/ml cytochrome 
 
c
 
, 
 
 
 
65% of
naïve cells were still viable at 3 h. Importantly, coinjection of
100 
 
 
 
g/ml cytochrome 
 
c
 
 with wild-type AVPI-Smac signifi-
cantly enhanced the amount of cell death, with 
 
 
 
25% of cells
remaining viable at 3 h (Fig. 4 D). Together, these results indi-
cate that reducing the activity of the apoptosome alone in naïve
cells was sufficient to allow endogenous IAPs to now effec-
tively regulate caspase activation and apoptosis.
 
Neuronally differentiated cells have 
decreased apoptosome activity because 
of markedly reduced Apaf-1 levels
 
Next, we examined whether the reduced apoptosome activity in
neuronally differentiated cells was due to limiting levels of
Apaf-1 or procaspase-9. We found that levels of Apaf-1, but
not caspase-9, were reduced by a striking 50% when naïve cells
were neuronally differentiated for 12 d (Fig. 5 A).
To determine whether the reduction in Apaf-1 levels was
specifically responsible for the decreased apoptosome activity
in neuronally differentiated cells, we examined the ability of
wild-type, Apaf-1
 
 
 
/
 
 
 
, and caspase-9
 
 
 
/
 
 
 
 cell lysates to comple-
ment the deficit in neuronally differentiated cell lysates. Cyto-
solic lysates from either wild-type, Apaf-1
 
 
 
/
 
 
 
, or caspase-9
 / 
fibroblast cells were incubated with neuronally differentiated
cell lysates and activated in the presence of cytochrome c and
dATP. Addition of wild-type or caspase-9
 /  cell lysate to neu-
ronally differentiated lysate allowed robust caspase activation
with cytochrome c (Fig. 5 B), indicating that one or more com-
ponents from these lysates were sufficient to complement the
deficiency and activate caspases in neuronally differentiated
cell lysate, without the need to overcome any IAP inhibition.
Lysates from naïve cells also complemented the defect in neu-
ronally differentiated cells (Fig. S2 B). In contrast, addition of
Apaf-1
 /  cell lysates failed to complement the apoptosome de-
ficiency of neuronally differentiated cells, as no activation of
caspases with cytochrome c were seen under these conditions
(Fig. 5 B). The inability of Apaf-1
 /  lysates to complement in
this experiment was not because of a nonspecific defect in the
preparation of these lysates, as addition of Apaf-1
 /  lysates to
caspase-9
 /  lysates fully complemented each other and acti-
vated caspases with cytochrome c (Fig. S2 C). These comple-
mentation studies indicate that the inability of cytochrome c
alone to activate caspases in neuronally differentiated cells was
because of a specific reduction in Apaf-1 function in these cells.
Figure 4. Reducing the apoptosome efficiency
with addition of suboptimum cytochrome c per-
mits endogenous IAPs to effectively block cas-
pase activation and apoptosis in naïve cells.
(A) Cytosolic lysates from naïve cells were in-
cubated with serial dilutions of cytochrome c
to identify a concentration of cytochrome c
that was suboptimum for caspase activation in
these extracts. (B) Naïve cytosolic extracts
were incubated with a suboptimum dose of
cytochrome c (100 nM) and 1  M of either
wild-type AVPI-Smac or mutant MVPI-Smac.
Data shown are representative of multiple ex-
periments. (C) Naïve PC12 cells were injected
with serial dilutions of cytochrome c to identify
a dose of cytochrome c that was suboptimum
for inducing cell death. (D) Naïve cells were
injected with a suboptimum dose of cyto-
chrome c (100  g/ml) and 1 mg/ml of either
wild-type AVPI-Smac or mutant MVPI-Smac.
Data shown are mean   SEM of three inde-
pendent experiments.JCB • VOLUME 167 • NUMBER 2 • 2004 308
Restoration of Apaf-1 levels in 
neuronally differentiated cells eliminates 
regulation by endogenous IAPs and 
sensitizes cells to cytochrome c
If the reduced apoptosome activity was crucial in enabling en-
dogenous IAPs to effectively regulate apoptosis postcytochrome
c in neuronally differentiated cells, then increasing Apaf-1 levels
should be sufficient to overcome the deficit in the apoptosome
and permit cytochrome c alone to activate caspases in neuronally
differentiated cells. Although cytochrome c alone did not induce
caspase activation, addition of Apaf-1 protein was remarkably
effective in permitting cytochrome c to induce robust caspase ac-
tivation in the neuronally differentiated cell lysates, without the
need to overcome IAP inhibition (Fig. 5 C). The amount of
Apaf-1 protein added (10 nM) was in the physiological range for
restoring Apaf-1 levels in the neuronally differentiated lysates,
as it was equivalent to the amount required for 50% of maximal
activation in Apaf-1 knock-out fibroblast lysates (Fig. S3, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200406073/DC1).
Also, the processing of caspase-9 seen in neuronally differenti-
ated extracts to which Apaf-1 was added was indicative of its re-
stored apoptosome efficiency with the p35 form (apoptosome
processed) predominating just as was seen in naïve cell extracts.
We also examined whether expression of Apaf-1 permit-
ted cytochrome c to induce apoptosis in intact neuronally differ-
entiated cells. Neuronally differentiated cells were injected with
plasmids expressing GFP and either Apaf-1 or vector alone. Af-
ter allowing 24 h for expression, the GFP-positive cells were in-
jected with cytochrome c to examine the ability of cytosolic cy-
tochrome c to induce apoptosis in these cells. As anticipated,
the neuronally differentiated cells expressing GFP and vector
alone were resistant to cytosolic injection of cytochrome c. In
contrast, increasing the levels of Apaf-1 permitted cytochrome
c to induce apoptosis, as  20% of the Apaf-1–expressing cells
remained viable 3 h after cytochrome c injections (Fig. 5 D). In-
jection of rhodamine dextran dye alone did not induce cell
death in Apaf-1–overexpressing cells. To determine whether
this effect was specific to Apaf-1, we examined whether over-
expression of procaspase-9 also made the neuronally differenti-
ated cells more vulnerable to cytosolic cytochrome c. No appre-
ciable increase in cell death was observed when cytochrome c
was injected in procaspase-9–overexpressing cells (Fig. 5 D).
Thus, restoring Apaf-1 levels eliminated the stringent postcyto-
chrome c regulation of apoptosis and allowed cytochrome c to
induce apoptosis rapidly and without the need to overcome any
endogenous IAP inhibition in neuronally differentiated cells.
Figure 5. A marked reduction in Apaf-1 levels
causes the reduced apoptosome activity in neuronally
differentiated cells. (A) Western blots comparing the
levels of Apaf-1, caspase-9, and lactate dehydroge-
nase (LDH) in naïve and neuronally differentiated cell
lysates. Quantitation of protein levels (mean   SEM
of three independent experiments) for Apaf-1 and cas-
pase-9 are shown. (B) The ability of exogenously
added cytochrome c (10  M) to activate caspases
was examined in cytosolic lysates of neuronally differ-
entiated PC12 cells alone (150  g) or neuronally dif-
ferentiated cell lysates (75  g) mixed with cytosolic
lysates from either wild-type, caspase-9
 / , or Apaf-
1
 /  fibroblasts (75  g). (C) Cytosolic lysate (150
 g) from neuronally differentiated cells was incubated
with cytochrome c alone (10  M) or cytochrome c
with Apaf-1 protein (10 nM) and assessed for cas-
pase activation. Western analysis of these lysates
probed for caspase-9 are shown below. (D) Neu-
ronally differentiated cells were injected with plasmid
DNA encoding EGFP (50 ng/ l) and plasmid DNA
for vector alone, Apaf-1, or caspase-9 (200 ng/ l).
After 24 h for DNA expression, GFP-positive cells
were injected with cytochrome c (10 mg/ml) or
rhodamine dextran and assessed for viability at the
indicated times after the injections. Data shown are
mean   SEM of three independent experiments.COUPLING OF APAF-1 AND IAP FUNCTION IN CELLS • WRIGHT ET AL. 309
Apaf-1 levels set the threshold for 
stringent postcytochrome c regulation 
of apoptosis by IAPs in primary 
mammalian cells
To test whether our model of coupling between Apaf-1 levels
and IAP function can extend beyond the PC12 cell paradigm,
we examined this in two different primary cell types. Our
model predicts that reducing Apaf-1 levels in a primary cell
would engage a strict regulation of cytochrome c–mediated
apoptosis by endogenous IAPs where such a regulation is oth-
erwise not detected. We examined this in cytosolic extracts of
primary dermal fibroblasts isolated from wild-type and Apaf-1
heterozygous mice. Exogenous cytochrome c induced robust
caspase activation in wild-type fibroblast lysates and addition
of Smac did not enhance caspase activation, indicating that en-
dogenous IAPs were ineffective in regulating caspase activa-
tion in wild-type fibroblasts (Fig. 6 A). In contrast, caspase ac-
tivation with cytochrome c was significantly reduced in Apaf-1
heterozygous fibroblast lysates. Importantly, this reduction in
cytochrome c–mediated caspase activation was not simply be-
cause of reduced Apaf-1 levels alone, but rather as a conse-
quence of the resulting increased regulation by IAPs, as addi-
tion of Smac allowed greater activation of caspases in Apaf-1
heterozygous extracts (Fig. 6 B).
We also examined whether the ability of endogenous
IAPs to strictly regulate apoptosis in primary sympathetic neu-
rons (at P5) (Deshmukh et al., 2002; Potts et al., 2003) was a
result of decreased Apaf-1 levels with neuronal differentiation.
First, we examined sympathetic neurons isolated from embry-
onic day 16 (E16) mice, a point at which a majority of these
neurons have begun postmitotic differentiation and are respon-
sive to NGF (Wyatt and Davies, 1995). After 2 d in culture,
these cells were microinjected with cytochrome c and were
found to undergo rapid apoptosis with cytochrome c alone (Fig.
7 A). In contrast, P3 sympathetic neurons maintained in culture
for 2 d (P5 equivalent) were remarkably resistant to microin-
jection of cytochrome c because of strict regulation by IAPs, as
described previously (Deshmukh and Johnson, 1998; Desh-
mukh et al., 2002). E16 sympathetic neurons maintained in cul-
ture for 8 d (P5 equivalent) also became markedly resistant to
cytochrome c (unpublished data).
To determine whether the differential regulation of apop-
tosis by IAPs was linked to changes in Apaf-1 levels, we exam-
ined the levels of Apaf-1 protein in E16 and P3 sympathetic
neurons after 2 d in culture. Levels of Apaf-1 were dramati-
cally reduced in P3 as compared with E16 neurons (Fig. 7 B).
In contrast, no differences in the levels of caspase-9, caspase-3,
or IAPs, as well as Smac and HtrA2, were observed in E16 ver-
sus P3 sympathetic neurons (Fig. 7 B; Fig. S4, available at http:
//www.jcb.org/cgi/content/full/jcb.200406073/DC1). We ex-
amined whether increasing Apaf-1 levels specifically had the
ability to overcome the strict IAP-mediated regulation of apop-
tosis seen in P5 sympathetic neurons. Primary P5 sympathetic
neurons were injected with plasmids expressing GFP and either
Apaf-1 or vector alone, and were subsequently reinjected with
cytochrome c to examine the ability of cytosolic cytochrome c
to induce apoptosis in these neurons. Increasing Apaf-1 levels
was remarkably effective in permitting cytochrome c to induce
apoptosis, without the need to overcome endogenous IAPs
in primary sympathetic neurons. Less than 20% of Apaf-1–
injected neurons were viable 6 h after cytochrome c injections
(Fig. 7, C and D). Importantly, overexpression of caspase-9
was ineffective in changing the resistance of these neurons to
cytochrome  c. These results show that primary sympathetic
neurons develop IAP-mediated resistance with neuronal matu-
ration by specifically down-regulating Apaf-1 levels.
Together, the results in primary fibroblasts and neurons
are consistent with the data in the PC12 cells and are indicative
of a novel common mechanism by which the effectiveness of
endogenous IAPs in regulating apoptosis is coupled to Apaf-1
levels in mammalian cells.
Discussion
Increased regulation of apoptosis by 
IAPs upon postmitotic neuronal 
differentiation
Despite their ubiquitous expression, endogenous IAPs appear
to stringently regulate apoptosis in neurons, but not in many
mitotic cells (Li et al., 1997; Brustugun et al., 1998; Juin et al.,
1999; Wiese et al., 1999; Chang et al., 2000; Holcik et al.,
Figure 6. Reduction of Apaf-1 in primary fibroblasts allows strict IAP-
mediated regulation of cytochrome c–mediated caspase activation. Cyto-
solic lysates were prepared from primary dermal fibroblasts from either
wild-type (A) or Apaf-1 heterozygous (B) mice. The ability of bovine cyto-
chrome c (10  M) alone or bovine cytochrome c and Smac (1  M) together
to activate caspases was examined in these lysates. Yeast cytochrome c
was added to these lysates as a negative control. Data shown are repre-
sentative of at least three independent experiments.JCB • VOLUME 167 • NUMBER 2 • 2004 310
2000; Deshmukh et al., 2002; Perrelet et al., 2002; Potts et al.,
2003). In this work, we investigated whether IAP function was
modulated in differentiating cells. We found that although cy-
tosolic cytochrome c was sufficient to activate caspases and in-
duce death in naïve PC12 cells, upon postmitotic differentia-
tion these cells became markedly resistant both in intact cells
and in cell-free extracts (Fig. 1). Likewise, cytochrome c was
sufficient to induce apoptosis in sympathetic neurons at early
(E16) but not in later (P3) stages of neuronal differentiation
(Fig. 7). The increased regulation of cytochrome c–mediated
apoptosis seen with postmitotic neuronal differentiation is un-
likely to be a consequence of exit from cell cycle alone. Naïve
PC12 cells stopped dividing and began extending neurites
within 2–4 d of NGF treatment, yet became resistant to cyto-
chrome c only after 10–12 d of differentiation (Fig. S1).
The marked resistance to cytosolic cytochrome c in neu-
ronally differentiated cells could be overcome with excess ma-
ture Smac, but not mutant Smac that does not inhibit IAPs (Fig.
2). These results indicate that the increased apoptotic regula-
tion seen in neuronally differentiated cells is mediated by en-
dogenous IAPs. While this manuscript was being prepared for
submission, Vyas et al. (2004) reported a similar observation,
where neuronally differentiated PC12 cells were shown to ex-
hibit an increased IAP-mediated resistance to cytochrome c.
These data in neuronally differentiated cells are strikingly sim-
ilar to what has been observed in primary P5 sympathetic neu-
rons, which are remarkably resistant to cytosolic cytochrome c
because of stringent regulation by endogenous IAPs (Desh-
mukh et al., 2002). Physiologically appropriate stimuli such as
trophic factor withdrawal are able to activate neuronal apopto-
sis because they induce not only the release of cytochrome c,
but also the degradation of XIAP, the specific IAP that regu-
lates death in these neurons (Potts et al., 2003).
Coupling of IAP function and apoptosome 
activity in cells
We were surprised to find that despite the striking difference in
IAP function in naïve and neuronally differentiated PC12 cells,
the levels of IAPs examined in these cells were similar (Fig. 3).
Also, no differences in the levels of Smac and HtrA2 were ob-
served in these cells (Fig. S2 A). How is it, then, that endoge-
nous IAPs are capable of regulating apoptosis in neuronally
Figure 7. Modulation of Apaf-1 levels determines the strict IAP regulation of caspases in developing primary sympathetic neurons. (A) Sympathetic neu-
rons from E16 and P3 mice were maintained in culture for 2 d and compared for the ability of cytochrome c to induce apoptosis by cytosolic microinjec-
tion of cytochrome c. (B) Levels of Apaf-1 and procaspase-9 were examined in whole-cell lysates of E16 and P3 sympathetic neurons after 2 d in culture.
Levels of lactate dehydrogenase (LDH) were examined as a loading control. (C) Primary sympathetic neurons (from P0 mice after 5 d in culture) were
injected with plasmid DNAs encoding EGFP (50 ng/ l) and vector alone, Apaf-1, or caspase-9 (200 ng/ l). After 24 h for DNA expression, GFP-positive
cells were injected with cytochrome c or rhodamine dextran and were assessed for viability at multiple times after the injections. Data shown are mean  
SEM of three independent experiments. (D) Model showing how a marked reduction in Apaf-1 activity with neuronal differentiation is coupled to the in-
creased effectiveness of endogenous IAPs in regulating cytochrome c–mediated apoptosis.COUPLING OF APAF-1 AND IAP FUNCTION IN CELLS • WRIGHT ET AL. 311
differentiated but not naïve cells? IAPs have been reported to
be regulated at the posttranslational level by mechanisms that
include ubiquitination and association with other proteins
(Salvesen and Duckett, 2002; LeBlanc, 2003). However, our
data indicate that the differential ability of IAPs to regulate
apoptosis is directly linked to the activity of the apoptosome in
cells. First, cytochrome c–induced apoptosome activity was
very efficient in naïve cells but highly inefficient in neuronally
differentiated cells, even under conditions where IAP inhibition
is relieved (Fig. 3 C). This decrease in apoptosome activity was
because of a specific reduction in Apaf-1 function, as Apaf-1
protein levels were markedly reduced in neuronally differenti-
ated cells. The time course of reduction in Apaf-1 levels corre-
lated well with the increasing resistance to cytochrome c in
cells undergoing differentiation (Fig. S1, C and D). Further-
more, the apoptosome defect in neuronally differentiated cells
could be fully complemented in vitro by wild-type and caspase-
9–deficient lysates, but not by Apaf-1–deficient lysates (Fig.
5). Second, decreasing the apoptosome activity by using subop-
timum cytochrome c in naïve cells enabled the endogenous
IAPs to become highly effective in blocking caspase activation
and cell death in these mitotic cells (Fig. 4). Third, increasing
the apoptosome activity in neuronally differentiated cells, by
restoring Apaf-1 levels, rendered the endogenous IAPs com-
pletely ineffective in regulating caspase activation (Fig. 5).
Thus, endogenous IAPs in naïve or neuronally differenti-
ated cells could be modulated to either be fully effective or in-
effective in regulating apoptosis simply by altering the apopto-
some activity in cells. These data argue against any intrinsic
differences in the IAPs in naïve and neuronally differentiated
cells. Importantly, our data in Apaf-1 heterozygous fibroblasts
and in neurons (Fig. 7) extend these observations to primary
cells, suggesting a shared mechanism of regulating IAP func-
tion in mammalian cells.
Based on these data, we suggest a model in which the ef-
fectiveness of IAPs in controlling apoptosis is tightly coupled
to the apoptosome activity in cells (Fig. 7 D). We propose that
although an efficient apoptosome renders endogenous IAPs in-
effective in blocking caspase activation in mitotic cells, postmi-
totic differentiation is accompanied by a marked reduction in
Apaf-1. The specific reduction in Apaf-1 protein leads to a de-
crease in apoptosome activity, which allows endogenous IAPs
to be highly effective in regulating apoptosis in postmitotically
differentiated cells such as neurons. For example, the reduction
in Apaf-1 protein would result in slow apoptosome processing
of the initiator procaspase-9 and provide IAPs an opportunity
to bind to activated caspase-9, and therefore prevent it from ac-
tivating caspase-3 and blocking apoptosis in neuronally differ-
entiated cells. This is supported by the data showing that al-
though relieving IAP inhibition with Smac permitted apoptosis
to occur in neuronally differentiated cells, this proceeded at a
slower rate as compared with mitotic naïve cells. This is likely
because of the overall slow processing of procaspases-9 as a re-
sult of reduced apoptosome efficiency in these cells (Fig. 2).
The exact mechanism by which Apaf-1 levels are re-
duced with neuronal differentiation is unknown. Like Apaf-1
protein, Apaf-1 mRNA is also markedly reduced with neuronal
differentiation (unpublished data; Yakovlev et al., 2001). Re-
cent reports have identified E2F1 and p53 as transcriptional
regulators of Apaf-1 (Moroni et al., 2001). As the transcrip-
tional activity of both E2F1 and p53 is decreased in neuronally
differentiated cells (Galderisi et al., 2003), these are likely to
contribute to the marked reduction in Apaf-1 levels seen in
these cells. Additionally, although Apaf-1 protein levels are re-
duced by 50% upon postmitotic neuronal differentiation, other
factors such as posttranslational modifications of Apaf-1 could
also contribute to the dramatic reduction in Apaf-1 activity in
neuronally differentiated cells.
Physiologically important functions of 
IAPs
The marked difference in the postcytochrome c regulation of
apoptosis observed between naïve and neuronally differenti-
ated PC12 cells suggests that a fundamental change in the regu-
lation of apoptosis may occur when any cell undergoes postmi-
totic differentiation. A strict regulation of apoptosis by IAPs is
an important safety brake that could protect against unwanted
caspase activation if cytochrome c is accidentally released
from damaged mitochondria in cells. Arguably, such a mecha-
nism would be physiologically important in postmitotically dif-
ferentiated cells such as neurons because these cells have lim-
ited regenerative potential and need to last for the lifetimes of
organisms. In contrast, rapid and efficient activation of cas-
pases in mitotic cells could be advantageous because of the po-
tential of these cells to have dysregulated proliferation.
In these neurons, physiologically appropriate apoptosis
during development occurring as a consequence of trophic fac-
tor withdrawal is dependent on both the release of cytochrome
c and the degradation of XIAP (Potts et al., 2003). Because nei-
ther event alone is capable of activating caspases and inducing
apoptosis in neurons, the lack of any developmental phenotype
observed in the XIAP-deficient mice (Harlin et al., 2001) is
not surprising. However, the XIAP-deficient neurons, like the
NAIP-deficient neurons (Holcik et al., 2000), are likely to be
more vulnerable to injury that causes direct mitochondrial
damage and rapid release of cytochrome c.
Lastly, results in this paper allow us to make several pre-
dictions. First, cells in which IAPs are found to strictly regulate
apoptosis may have reduced apoptosome activity. Indeed, we
tested this prediction in primary sympathetic neurons and found a
marked reduction in Apaf-1 levels accompanying neuronal dif-
ferentiation. Furthermore, elevating Apaf-1 levels specifically in
P5 neurons resulted in the elimination of the strict XIAP control
of apoptosis that is otherwise seen in these neurons (Fig. 7). In
many cancer cells where endogenous IAPs effectively block
apoptosis (Deveraux and Reed, 1999; Liston et al., 2003), we
predict that a reduction in apoptosome activity may have the
same effective outcome as observed with elevated levels of IAPs.
Second, cells that are known to have reduced Apaf-1 lev-
els may be subject to strict regulation by endogenous IAPs.
Indeed, postmitotically differentiated cells such as mature
cortical neurons (Yakovlev et al., 2001; Ota et al., 2002), car-
diomyocytes (Sanchis et al., 2003), and skeletal muscle cells
(Burgess et al., 1999) have significantly reduced or no detect-JCB • VOLUME 167 • NUMBER 2 • 2004 312
able Apaf-1 levels, and are resistant to cytochrome c–induced
apoptosis. Our results predict that the resistance to cytochrome
c seen in these cells could be because of a strict regulation of
caspase activation by endogenous IAPs that becomes effective
because of the marked reduction in Apaf-1 levels and the sub-
sequent reduction in apoptosome activity.
Materials and methods
Reagents
All reagents were purchased from Sigma-Aldrich or Fisher scientific, unless
otherwise stated. Collagenase and trypsin were purchased from Wor-
thington Biochemical Corporation. The Apaf-1 cDNA was a gift from Dr.
Gabriel Nuñez (University of Michigan, Ann Arbor, MI) and the caspase-9
cDNA was a gift from Dr. Chunying Du (Stowers Institute, Kansas City,
MO). Apaf-1 knockout and wild-type mouse embryonic fibroblasts were
provided by Dr. Douglas Green (La Jolla Institute for Allergy and Immunol-
ogy, La Jolla, CA). Apaf-1 protein was provided by Dr. Xiaodong Wang
(University of Texas Southwestern, Dallas, TX) and tested for its ability to
complement the Apaf-1 knockout lysates (Fig. S3).
Cell culture
PC6-3, a subline of PC12 cells, was provided by Dr. Randy Pittman (Uni-
versity of Pennsylvania, Philadelphia, PA; Pittman et al., 1993). PC12
cells were maintained in their mitotic naïve state in RPMI 1640 supple-
mented with 10% heat-inactivated horse serum, 5% FBS, 100  g/ml peni-
cillin, 100  g/ml streptomycin, and 250 ng/ml amphotericin. Glucose
was added to a final concentration of 4,500 mg/l. PC12 cells were neu-
ronally differentiated by plating at a density of 10
4 cells/cm
2 on collagen-
coated dishes in complete media supplemented with 50 ng/ml NGF. Cell
culture media was replenished every 2 d, and on d 8 media was removed
and replaced with serum-free RPMI 1640 (4,500 mg/l glucose) supple-
mented with 50 ng/ml NGF. Experiments were performed on neuronally
differentiated cells at d 12 of differentiation.
Primary dermal fibroblasts were isolated from P0 mice. The dorsal
skin was removed and treated with 1 mg/ml collagenase, and then with
2.5 mg/ml trypsin for 1 h each at 37 C. Tissue was then triturated and the
dissociated cells were plated in DME supplemented with 10% FBS and
100  g/ml penicillin and 100  g/ml streptomycin.
Primary sympathetic neurons were isolated from E16 and P1 or P3
mice and maintained in culture as described previously (Deshmukh and
Johnson, 1998). In brief, dissected ganglia were treated with 1 mg/ml
collagenase, and then with 2.5 mg/ml trypsin for 30 min each at 37 C.
Ganglia were triturated, and dissociated cells were plated on collagen-
coated plates in MEM with Earle’s salts supplemented with 50 ng/ml NGF,
10% FCS, 2 mM glutamine, 100  g/ml penicillin, 100  g/ml streptomy-
cin, 20  M fluorodeoxyuridine, 20  M uridine, and 3.3  g/ml aphidi-
colin. Experiments were performed on cells 2–5 d after plating.
Microinjections
Cells were microinjected on 35-mm plates using Femtotip II needles (Ep-
pendorf Inc.) or needles pulled on a Flaming-Brown horizontal micro-
pipette puller (Sutter Instruments) and a Narashigi micromanipulator
mounted on an inverted fluorescence microscope (Leica). Between 75 and
150 cells were injected for each condition in these experiments. The mi-
croinjection solution contained 100 mM KCl and 10 mM KPi, pH 7.4. For
injections involving plasmid DNAs, neuronally differentiated PC12 cells
were injected with the DNA after 11 d of differentiation and sympathetic
neurons were injected 4 d after plating. The microinjection solution in-
cluded 50 ng/ l of enhanced EGFP (CLONTECH Laboratories, Inc.) plas-
mid and 200 ng/ l of either caspase-9– or Apaf-1–expressing plasmid
DNAs. After 24 h to allow for expression, the GFP-positive cells were rein-
jected with cytochrome c. For these injections, the microinjection buffer
contained rhodamine dextran with cytochrome c prepared fresh and di-
luted to various concentrations in water. Where indicated, the wild-type
AVPI-Smac and the mutant MVPI-Smac proteins (Potts et al., 2003) were
added to the microinjection buffer at a final concentration of 1  g/ l. Af-
ter microinjections, viable cells were identified as rhodamine-positive cells
that had intact, phase-bright cell bodies (Deshmukh and Johnson, 1998).
Cytosolic extracts for caspase activation assays
Cells were harvested by scraping and the cell pellet was washed once in
ice-cold PBS and resuspended in a volume of hypotonic buffer (10 mM
Hepes, pH 7.5, 10 mM KCl, 0.5 mM EDTA, 1 mM EGTA, 1 mM MgCl2, 1
mM DTT, pepstatin, leupeptin, and aprotinin) equal to three times the pellet
volume. After 20 min of incubation at 4 C on a tumbler, cells were lysed
by passage through a 27-gauge needle. Cells were then centrifuged for 30
min at 16,000 g to remove intact cells, nuclei, and heavy membranes. The
lysate was centrifuged at 100,000 g for 1 h to remove light membranes,
and the resulting supernatant was used for caspase activation assays.
In vitro caspase activation assays were performed using equal pro-
tein from naïve and differentiated PC12 cell cytosolic lysate. PC12 cell
(150  g) or dermal fibroblast (100  g) cytosolic extracts were incubated
with various concentrations of cytochrome c and 1 mM dATP in Apaf-1 oli-
gomerization buffer (25 mM Hepes, pH 7.5, 50 mM NaCl, 10 mM KCl,
1.5 mM MgCl2, 10% glycerol, 1 mM DTT) in a final volume of 100  l at
37 C for 30 min. After incubation with the fluorogenic caspase substrate
50  M DEVD-afc (Biomol Research Laboratories), the caspase activity was
measured at 37 C on a Fluoroskan Ascent fluorescent plate reader (Ther-
moLabsystems). Where indicated 1 mM MVPI-Smac, 1 mM AVPI-Smac,
10 nM Apaf-1 protein, or 7 U granzyme B (Sigma-Aldrich) was added to
the lysates.
Western blots
Western blots were performed as described previously (Potts et al.,
2003). Primary antibodies used were as follows: anti-XIAP (AF822; R&D
Systems); anti-cIAP1 (AF818; R&D Systems); anti-cIAP2 (AF817; R&D Sys-
tems); anti-Smac (AF7891; R&D Systems); anti-HtrA2 (AF1458; R&D Sys-
tems); anti-caspase–9 (M0543; MBL International Corporation); anti-
cleaved caspase-3 (9661; Cell Signaling); anti-procaspase-3 (9665; Cell
Signaling); anti-Apaf-1 (13F11; Alexis Biochemicals), and anti-NAIP (AF829;
R&D Systems). Anti-Apaf-1 antibody, clone Apaf-1L91-71 (a gift of Dr.
Yuri Lazebnik, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY)
was used for the Western analysis of primary sympathetic neurons. Anti–
mouse/rabbit HRP conjugated secondary antibodies were purchased from
Pierce Chemical Co. Proteins were detected using the ECL-Plus detection
system (Amersham Biosciences). Protein levels were quantified by scan-
ning blots on a Typhoon scanner (Amersham Biosciences) and analysis
with ImageQuant software (Amersham Biosciences).
Online supplemental material
Fig. S1 shows the time course of the development of resistance to cytosolic
cytochrome c during neuronal differentiation of PC12 cells. Also shown is
its correlation with the time course of reduction in Apaf-1 levels during
neuronal differentiation. Fig. S2 includes Western blots showing levels of
Smac, HtrA2, and procaspase-3 in naïve and neuronally differentiated
PC12 cells. Also included are data from two cell-free complementation
experiments. First, that cytosolic lysates of naïve and neuronally differ-
entiated PC12 cells complement each other and permit cytochrome c to
activate caspases. Second, that cytosolic lysates of Apaf-1
 /  and cas-
pase-9
 /  fibroblasts complement each other and permit cytochrome c to
activate caspases. Fig. S3 tests the functionality of the Apaf-1 protein and
shows that the Apaf-1 protein can complement the Apaf-1
 /  mouse em-
bryonic fibroblast lysates in a cell-free caspase activation assay. Fig. S4
includes representative Western blots showing levels of various IAPs,
Smac, HtrA2, and procaspase-3 in E16 and P3 primary sympathetic neu-
rons. Online supplemental material available at http://www.jcb.org/cgi/
content/full/jcb.200406073/DC1.
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